JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis

Janus kinase (JAK) inhibitors are widely used in the treatment of multiple autoimmune and inflammatory diseases. Immunologic and transcriptomic profiling have revealed major alterations on natural killer (NK) cell homeostasis associated with JAK inhibitions, while information on other innate lymphoi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Vian, Laura, Le, Mimi T., Gazaniga, Nathalia, Kieltyka, Jacqueline, Liu, Christine, Pietropaolo, Giuseppe, Dell'Orso, Stefania, Brooks, Stephen R., Furumoto, Yasuko, Thomas, Craig J., O'Shea, John J., Sciumè, Giuseppe, Gadina, Massimo
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930870/
https://ncbi.nlm.nih.gov/pubmed/31921209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02972
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items